Designed and developed incorporating segregated areas for the manufacture of both injectable and non-injectable products with specific processing including, Cytotoxics, TPN, Civas, biologics as well as radio-pharmacy operations.

Operating as a specialist sub-contractor within the framework of a larger facility construction by a leading Main Contractor; CDCfm’s responsibilities included direct liaison with the Trust user team to develop, agree, design and fully validate all aspects of the facility for MHRA regulatory compliance.

With CDCfm’s in-house team responsible for the specification and agreement of all architectural finishes along with the necessary engineering solution this provided the Trust a risk-free delivery strategy.